A role for chemistry in stem cell biology
- 30 June 2004
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 22 (7) , 833-840
- https://doi.org/10.1038/nbt987
Abstract
Although stem cells hold considerable promise for the treatment of numerous diseases including cardiovascular disease, neurodegenerative disease, musculoskeletal disease, diabetes and cancer, obstacles such as the control of stem cell fate, allogenic rejection and limited cell availability must be overcome before their therapeutic potential can be realized. This requires an improved understanding of the signaling pathways that affect stem cell fate. Cell-based phenotypic and pathway-specific screens of natural products and synthetic compounds have recently provided a number of small molecules that can be used to selectively control stem cell proliferation and differentiation. Examples include the selective induction of neurogenesis and cardiomyogenesis in murine embryonic stem cells, osteogenesis in mesenchymal stem cells and dedifferentiation in skeletal muscle cells. Such molecules will likely provide new insights into stem cell biology, and may ultimately contribute to effective medicines for tissue repair and regeneration.Keywords
This publication has 57 references indexed in Scilit:
- Evidence of a Pluripotent Human Embryonic Stem Cell Line Derived from a Cloned BlastocystScience, 2004
- Derivation of embryonic germ cells and male gametes from embryonic stem cellsNature, 2003
- Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cellsNature Biotechnology, 2003
- Embryonic stem cells can form germ cells in vitroProceedings of the National Academy of Sciences, 2003
- Derivation of Oocytes from Mouse Embryonic Stem CellsScience, 2003
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- HSP90 as a new therapeutic target for cancer therapy: the story unfoldsExpert Opinion on Biological Therapy, 2002
- Bortezomib, a proteasome inhibitor, in cancer therapy: From concept to clinicDrugs of the Future, 2002
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Transfection of a DNA locus that mediates the conversion of 10T12 fibroblasts to myoblastsCell, 1986